Sökning: "bröstcancer"
Visar resultat 31 - 35 av 177 avhandlingar innehållade ordet bröstcancer.
31. Phosphatidylethanol - formation and degradation in blood and organs
Sammanfattning : Phosphatidylethanol (PEth) is an abnormal phospholipid formed exclusively by the action of phospholipase D (PLD) in the presence of ethanol. The degradation of PEth is slow and due to its accumulation in some cells the possibility to use PEth as marker of ethanol intake has been proposed. LÄS MER
32. Hunting a Silent Killer. Biomolecular Approaches in Ovarian Cancer
Sammanfattning : Ovarian cancer is a heterogeneous disease and recent advances in improving patient outcome havebeen limited. It is estimated that a woman’s risk of developing ovarian cancer during her lifetime is about 1 in 70, making it a frequently occurring cancer type in women. LÄS MER
33. Towards improved management of Lynch syndrome; ovarian cancer profiles, risk perception, knowledge and family perspectives
Sammanfattning : Lynch syndrome (hereditary nonpolyposis colorectal cancer) is one of the most common hereditary cancer syndromes and predisposes to several cancer types, including cancer of the colorectum, endometrium and ovaries. Cancer develops at an early age and one third of the individuals are affected by a metachronous cancer. LÄS MER
34. FDG-PET in Cervical Cancer - Translational Studies
Sammanfattning : Cervical cancer is the second most common cancer in females. The treatment, based on clinical FIGO stage, carries a significant risk of side effects. FDG-PET enables non-invasive studies of glucose metabolism. Cancer cells show an increased glucose uptake and metabolism that can be visualised and further analysed. LÄS MER
35. Head and Neck Cancer: Studies on microvessel density, radiation response and FDG PET
Sammanfattning : Treatment options of head and neck squamous cell carcinoma (HNSCC) usually include combinations of radiotherapy and surgery, and in some cases addition of chemotherapy. In locally advanced cases cure rates are low. Current prognostic factors cannot foresee the outcome for the individual patient. LÄS MER